Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.

Schetelig, Johannes; Chevallier, Patrice; van Gelder, Michel; Hoek, Jennifer; Hermine, Olivier; Chakraverty, Ronjon; Browne, Paul; Milpied, Noel; Malagola, Michele; Socié, Gerard; Delgado, Julio; Deconinck, Eric; Damaj, Ghandi; Maury, Sebastian; Beelen, Dietrich; Quoc, Stéphanie Nguyen; Shankara, Paneesha; Brecht, Arne; Mayer, Jiri; Hunault-Berger, Mathilde; Bittenbring, Jörg; Thieblemont, Catherine; Lepretre, Stéphane; Baldauf, Henning; de Wreede, Liesbeth C; Tournilhac, Olivier; Yakoub-Agha, Ibrahim; Kröger, Nicolaus; Dreger, Peter

Abstract

No abstract available

Citation

Schetelig J, Chevallier P, van Gelder M, Hoek J, Hermine O, Chakraverty R, Browne P, Milpied N, Malagola M, Socié G, Delgado J, Deconinck E, Damaj G, Maury S, Beelen D, Quoc SN, Shankara P, Brecht A, Mayer J, Hunault-Berger M, Bittenbring J, Thieblemont C, Lepretre S, Baldauf H, de Wreede LC, Tournilhac O, Yakoub-Agha I, Kröger N, Dreger P. Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party. Bone Marrow Transplant. 2022 Feb;57(2):330. doi: 10.1038/s41409-021-01516-2. Erratum for: Bone Marrow Transplant. 2021 Mar;56(3):605-613. doi: 10.1038/s41409-020-01069-w

Type

Correspondence